Skip to main content
Erschienen in: Clinical Hypertension 1/2023

Open Access 01.12.2023 | Letter to the Editor

Arterial hypertension in Leigh syndrome due to m.13513G > A is multicausal, requiring an extensive search to identify its pathphysiology

verfasst von: Josef Finsterer

Erschienen in: Clinical Hypertension | Ausgabe 1/2023

Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Letter to the editor

We read with interest the article by Solis et al. on a 3 years and 10 months-old female with Leigh syndrome due to the variant m.13513G > A in MT-ND5 with a heteroplasmy rate of 69% [1]. Leigh syndrome phenotypically manifested with developmental delay, hypotonia, failure to thrive, lactic acidosis, multiple, bilaterally symmetric DWI hyperintensities in the sub-thalamic nuclei, brainstem, and upper cervical spine, strabismus, Wolff-Parkinson-White (WPW) syndrome, obstructive sleep apnoea, hypo-gamma-globulinemia, proximal tubular acidosis, and renal cysts [1]. By age 3y, malignant arterial hypertension associated with increased catecholamines developed, but extensive investigations were inconclusive as to why the hypertensive crises were attributed to catecholamine-induced autonomic dysfunction [1]. The study is excellent but has limitations that should be discussed.
The main limitation of the study is that multiple causes of arterial hypertension were not adequately ruled out. Arterial hypertension is a well-known phenotypic feature of mitochondrial disorders (MIDs) and has been reported particularly in Chinese MID patients [2]. Therefore, it is conceivable that arterial hypertension was simply a phenotypic manifestation of the mtDNA mutation. An argument for this speculation is that arterial hypertension has previously been reported in m.13513G > A carriers [2]. In a 12 months-old infant, the m.13513G > A variant manifested with tachy-arrhythmias, hyponatriemia, inappropriate ADH secretion, cardiomyopathy, WPW-syndrome, and arterial hypertension [3].
There is also evidence that MIDs manifest with neoplasms more commonly than non-MIDs. Therefore, we should know whether catecholamine-producing neoplasms, benign or malign, have been excluded as the cause of hypertension in the index patient. In particular, extra-suprarenal pheochromocytoma or paraganglioma must be ruled out. The 18 F-FDOPA PET/CT can be helpful in this respect but a negative result does not rule out paraganglioma [4].
Another unaccounted cause of arterial hypertension is an ACTH-producing micro- or macro-adenoma of the pituitary gland. Pituitary adenoma can be a phenotypic manifestation of MIDs, making it crucial that such neoplasms are adequately ruled out. However, serum cortisol levels were not determined and no dexamethasone suppression test was performed. A negative dexamethasone suppression test does not rule out non-ACTH producing pituitary adenoma.
Another cause of arterial hypertension in patients with Leigh syndrome is increased intra-cranial pressure [5]. Therefore, an ophthalmologic examination to rule out papilledema or a lumbar puncture and direct measurement of the intra-cranial pressure is mandatory.
It is also conceivable that arterial hypertension resulted from unwitnessed generalised seizures or non-convulsive status epilepticus. Since Leigh syndrome is often associated with seizures, we should know if epileptiform discharges were recorded on EEG.
We disagree with the classification of DWI hyperintensities as ischemic stroke [1]. Ischemic stroke is characterised by DWI hyperintensity and hypointensity on apparent diffusion coefficient (ADC) maps (cytotoxic edema). However, no ADC maps have been described or shown in a figure. Another argument against ischemic stroke is the symmetry of the lesions. These lesions are typically of Leigh syndrome but atypically of ischemic stroke. A third argument against ischemic stroke is that the lesions were small and not confined to a vascular territory.
There is no mention of the family history, particularly whether the index patient’s mother also carried the MT-ND5 variant and whether she manifested phenotypically with arterial hypertension. mtDNA variants are transmitted via the maternal line in 75% of cases [6]. Therefore, it is necessary not only to examine the mother clinically but also to test her genetically.
Overall, the interesting study has limitations that call the results and their interpretation into question. Clarifying these weaknesses would strengthen the conclusions and could improve the study. Arterial hypertension in Leigh syndrome can be multicausal, thus requiring comprehensive workup to identify the underlying pathphysiology.

Acknowledgements

None.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
2.
Zurück zum Zitat Guo H, Guo L, Yuan Y, Liang XY, Bi R. Co-occurrence of m.15992A > G and m.15077G > A is Associated with a high penetrance of maternally inherited hypertension in a chinese pedigree. Am J Hypertens 2022 Jan 5;35(1):96–102. doi: https://doi.org/10.1093/ajh/hpab123. Guo H, Guo L, Yuan Y, Liang XY, Bi R. Co-occurrence of m.15992A > G and m.15077G > A is Associated with a high penetrance of maternally inherited hypertension in a chinese pedigree. Am J Hypertens 2022 Jan 5;35(1):96–102. doi: https://​doi.​org/​10.​1093/​ajh/​hpab123.
5.
Zurück zum Zitat Tabarki B, Al-Hashem A, Alfadhel M, Biotin-Thiamine-Responsive Basal Ganglia D. 2013 Nov 21 [updated 2020 Aug 20]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. Tabarki B, Al-Hashem A, Alfadhel M, Biotin-Thiamine-Responsive Basal Ganglia D. 2013 Nov 21 [updated 2020 Aug 20]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023.
Metadaten
Titel
Arterial hypertension in Leigh syndrome due to m.13513G > A is multicausal, requiring an extensive search to identify its pathphysiology
verfasst von
Josef Finsterer
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
Clinical Hypertension / Ausgabe 1/2023
Elektronische ISSN: 2056-5909
DOI
https://doi.org/10.1186/s40885-023-00247-4

Weitere Artikel der Ausgabe 1/2023

Clinical Hypertension 1/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.